SYSTEMIC FRONT LINE THERAPY OF FOLLICULAR LYMPHOMA: WHEN, TO WHOM AND HOW
The natural history of follicular lymphoma is usually characterized by an indolent course with a high response rate to the first line therapy followed by recurrent relapses, with a time to next treatment becoming shorter after each subsequent treatment line. More than 80% of patients have advanced s...
Saved in:
| Main Authors: | Francesca Pavanello, Sara Steffanoni, Michele Ghielmini, Emanuele Zucca |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PAGEPress Publications
2016-11-01
|
| Series: | Mediterranean Journal of Hematology and Infectious Diseases |
| Subjects: | |
| Online Access: | http://www.mjhid.org/index.php/mjhid/article/view/2787 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy, safety and cost-effectiveness of obinutuzumab in patients with follicular lymphoma: a rapid review
by: Chao Wang, et al.
Published: (2025-01-01) -
LIMITED STAGE FOLLICULAR LYMPHOMA: THE ROLE OF RADIATION THERAPY.
by: Andrea Riccardo Filippi
Published: (2016-09-01) -
FOLLICULAR LYMPHOMA: THE MANAGEMENT OF ELDERLY PATIENT
by: Alessia Castellino, et al.
Published: (2017-01-01) -
CAR-T CELL THERAPY FOR FOLLICULAR LYMPHOMAS
by: Ugo Testa, et al.
Published: (2024-01-01) -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
by: Giuseppe Rossi, et al.
Published: (2016-11-01)